 PALO ALTO, Calif. and SACRAMENTO, Calif., April 13, 2021 GLOBE NEWSWIRE -- BridgeBio Pharma, Inc. NASDAQ: BBIO today announced a collaboration with the University of California, Davis UC Davis, to advance research and the development of investigational medicines for patients with genetically driven conditions and cancers. 